Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Inventory (2018 - 2025)

Historic Inventory for Agios Pharmaceuticals (AGIO) over the last 7 years, with Q4 2025 value amounting to $32.9 million.

  • Agios Pharmaceuticals' Inventory rose 1920.63% to $32.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $32.9 million, marking a year-over-year increase of 1920.63%. This contributed to the annual value of $32.9 million for FY2025, which is 1920.63% up from last year.
  • Agios Pharmaceuticals' Inventory amounted to $32.9 million in Q4 2025, which was up 1920.63% from $32.0 million recorded in Q3 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Inventory peaked at $32.9 million during Q4 2025, and registered a low of $2.5 million during Q1 2022.
  • Its 4-year average for Inventory is $19.4 million, with a median of $21.1 million in 2023.
  • Per our database at Business Quant, Agios Pharmaceuticals' Inventory skyrocketed by 35770.62% in 2023 and then soared by 1920.63% in 2025.
  • Quarter analysis of 4 years shows Agios Pharmaceuticals' Inventory stood at $8.5 million in 2022, then skyrocketed by 124.63% to $19.1 million in 2023, then surged by 44.77% to $27.6 million in 2024, then rose by 19.21% to $32.9 million in 2025.
  • Its last three reported values are $32.9 million in Q4 2025, $32.0 million for Q3 2025, and $30.8 million during Q2 2025.